Zantac Alternative Drugs Recommended By The FDA May Cause Memory Loss

The side effects of protein pump inhibitor drugs may include temporary or permanent memory loss

Tuesday, October 27, 2020 - The latest and greatest problem that plagues protein pump inhibitor drugs is patient memory loss. Researchers are unclear whether or not the memory loss is temporary as studies have only been performed in the short term. Clinical trials at Ohio State University by Clinical Psychology Researcher Annelise Madison discovered, "memory problems were between 20% and 29% more severe than those reported by patients who didn't use PPI's," according to WQAD8.com, a news station in Davenport, Iowa. The implication is that the longer one uses PPIs the more severe and long-lasting memory loss could be. Zantac stomach cancer lawsuit attorneys offer a free no obligation consultation to families and people that developed stomach cancer from taking the antacid Zantac.

The US Food and Drug Administration (FDA) initially recommended that people stop taking Zantac (ranitidine), an H2 histamine blocker, and switch to another class of drugs called protein pump inhibitors (PPIs). The best selling PPI drugs include brand names Prilosec, Prevacid, and Nexium. These drugs did not test positive, unlike Zantac, for elevated levels of a cancer-causing substance called N-Nitrosodimethylamine (NDMA), and are still on the market.

NDMA is a carcinogenic byproduct of industrial production commonly found in low levels in the air, land, and water. Online drug testing pharmacy Valisure tested Zantac and found levels of NDMA over 1 million nanograms (ngs) per capsule, far exceeding the FDA guidelines of 96 ngs. Valisure immediately reported their findings to the FDA prompting Sanofi, the maker of Zantac to recall the world's best selling anti-heartburn and acid reflux medicine. The FDA recalled all ranitidine products about a month later.

PPI drugs have a long list of side effects, not the least of which is contributing to type-2 diabetes. A British medical journal has linked the long-term use of Protein Pump Inhibitors to an increased risk of developing Type-2 diabetes.

According to Diabetes In Control.com, "long-term PPI users (>2 years) have a 24% higher risk of developing diabetes compared to non-PPI users," according to the BMJ. Also, PPI drugs (may cause) other medical problems including, "... an increased risk of bone fractures, chronic kidney disease, gut infections such as C. difficile, vitamin B12 deficiency, and stomach cancer."

Zantac was recalled by the FDA earlier in 2020 due to finding accelerated levels of NDMA many thousands of times greater than the level thought to be safe. The FDA recommended the switch to PPI drugs, but those drugs are quickly turning out to have life-threatening problems of their own. The FDA is now caught between a rock and a hard place because to recall PPI drugs would mean that heartburn and acid reflux sufferers would have nothing to turn to besides living a more healthy lifestyle to try and curb their indigestion. Individuals have developed a variety of cancer allegedly from taking Zantac like stomach, bladder, esophagus, prostate, and breast cancer. Many have hired Zantac cancer lawyers to help them file a claim against Sanofi for failing to warn them of the health consequences of the medicine.

More Recent Heartburn MedicineLawsuit News:

• WebMD Video Tells Viewers How To Replace Antacid Medicine Like Zantac With Healthy Diet Choices | 4/24/2021
• Zantac Unlikely To Return To The Market Soon | 4/23/2021
• Heartburn and Acid Reflux May Indicate You Have A Serious Disease | 4/21/2021
• NDMA Is In The Water, Soil, and Air | 4/19/2021
• Zantac Cancer Victims Should Start Gathering Their Medical Records | 4/14/2021
• Sanofi and GSK May Have Known Ranitidine Degrades And Covered It Up | 4/13/2021
• Heartburn May Be The Body's Way of Saying You Are Eating Too Much Of The Wrong Food | 4/12/2021
• Zantac Cancer Litigation Moving Forward | 4/8/2021
• Sanofi and GalaxoSmithKline May Have Known Zantac Could Cause Cancer | 4/6/2021
• Millions of Americans Are At Risk For Zantac Cancer | 4/2/2021
• Zantac (Ranitidine) May Cause Nitrates Found In The Stomach To Become More Carcinogenic | 4/1/2021
• Zantac Plaintiffs Could Number In The Thousands Eventually | 3/31/2021
• Zantac Could Be Responsible For The Obesity Epidemic | 3/28/2021
• Zantac Cancer Lawsuits By The Loved Ones of Those Who Have Died From Cancer | 3/24/2021
• Heartburn Sufferers Are Patiently Awaiting Zantac Cancer Trials | 3/22/2021
• The Zantac Cancer Scare Indicates A Need For Prescription Testing | 3/18/2021
• Avoid Fried Foods And Dairy Products If You Suffer From Heartburn And Indigestion | 3/17/2021
• The World Looks To Scientific Studies To Explain Zantac's NDMA Contamination | 3/16/2021
• Juries May Have To Decide If Zantac Causes Cancer | 3/15/2021
• Former Zantac Users Warned PPI Drugs May Be Deadly Also | 3/12/2021

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.